TrialAmerican journal of nephrology2022

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.

Rajiv Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.